The fact
This delisting severely impacted revenues of the French laboratory specialized in homeopathic products.
Boiron must reinvent itself commercially faced with drastically reduced reimbursed sales channels.
Click the link to read an article on the topic:
Observed impact
Impact récessif sur les ventes de Boiron depuis le déremboursement de l'homéopathie
Restructuration commerciale du laboratoire pour diversifier ses sources de revenus